You are here

The Journal of clinical investigation DOI:10.1172/JCI71545

SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.

Publication TypeJournal Article
Year of Publication2014
AuthorsWatanabe, H, Ma, Q, Peng, S, Adelmant, G, Swain, D, Song, W, Fox, C, Francis, JM, Pedamallu, CS, Deluca, DS, Brooks, AN, Wang, S, Que, J, Rustgi, AK, Wong, KK, Ligon, KL, Liu, XS, Marto, JA, Meyerson, M, Bass, AJ
JournalThe Journal of clinical investigation
Date Published2014/04/01

The transcription factor SOX2 is an essential regulator of pluripotent stem cells and promotes development and maintenance of squamous epithelia. We previously reported that SOX2 is an oncogene and subject to highly recurrent genomic amplification in squamous cell carcinomas (SCCs). Here, we have further characterized the function of SOX2 in SCC. Using ChIP-seq analysis, we compared SOX2-regulated gene profiles in multiple SCC cell lines to ES cell profiles and determined that SOX2 binds to distinct genomic loci in SCCs. In SCCs, SOX2 preferentially interacts with the transcription factor p63, as opposed to the transcription factor OCT4, which is the preferred SOX2 binding partner in ES cells. SOX2 and p63 exhibited overlapping genomic occupancy at a large number of loci in SCCs; however, coordinate binding of SOX2 and p63 was absent in ES cells. We further demonstrated that SOX2 and p63 jointly regulate gene expression, including the oncogene ETV4, which was essential for SOX2-amplified SCC cell survival. Together, these findings demonstrate that the action of SOX2 in SCC differs substantially from its role in pluripotency. The identification of the SCC-associated interaction between SOX2 and p63 will enable deeper characterization the downstream targets of this interaction in SCC and normal squamous epithelial physiology.